Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Jul 3, 2024, 23:31 |
Blog
A few papers to read about Precision oncology and use of AI suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah: "1. In advanced prostate cancer, deep learning…
Jul 3, 2024, 06:28 |
Blog
Yelak Biru: Is myeloma science and clinical progress fast or slow?
Yelak Biru, President and CEO at the International Myeloma Foundation, shared on X: "Is myeloma…
Jul 2, 2024, 22:59 |
Blog
Society for Immunotherapy of Cancer's Clinical Practice Guidelines to improve patient outcomes
Society for Immunotherapy of Cancer shared on LinkedIn: "Implement the latest FDA-approved cancer immunotherapies into practice…
Jul 2, 2024, 13:15 |
Blog
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
Lisa A. Lacasse shared on LinkedIn: “We are celebrating some phenomenal wins this week at…
Jul 2, 2024, 13:03 |
Insight
Maciej M Mrugala: Updates in advanced urothelial carcinoma at the Mayo Clinic and University of Athens meeting
Petros Grivas shared a post by Maciej M Mrugala, Director-Neuro-Oncology Fellowship Program at Mayo Clinic on…
Jul 2, 2024, 11:12 |
Blog
Enrique Grande: Fabulous and inspiring view of the short term future of advanced bladder cancer
Enrique Grande shared a post on X: …
Jul 1, 2024, 16:19 |
Insight
Vivek Subbiah: Two back to back futuristic papers in the journal AI In Precision Oncology
Vivek Subbiah shared on LinkedIn: “Thrilled to have the opportunity to mentor some of the…
Jul 1, 2024, 15:15 |
Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jul 1, 2024, 14:23 |
Blog
Jia Liu: Ensuring sponsors enrol patients on trials with diversity in sex, age, ethnicity and race
Jia Liu, Translational Researcher at The Kinghorn Cancer Centre, shared a post by FDA on…
Jul 1, 2024, 13:53 |
Drugs
Todd Davis: Approval of Verona Pharma’s Ohtuvayre
Todd Davis, CEO at Ligand Pharmaceuticals, shared on LinkedIn: "When I stepped in as CEO…
48
49
50
51
52
All:
946
Posts:
491 - 500
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube